Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V P Miller

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2000
Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substratesD M Stresser, A P Blanchard, S D Turner, et al.
Clinical Pharmacology and Therapeutics|February 11, 2000
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activityF Sata, A Sapone, G Elizondo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 15, 2001
The use of 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomesN Chauret, B Dobbs, R L Lackman, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 30, 2000
Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substratesD M Stresser, A P Blanchard, S D Turner, et al.
Clinical Pharmacology and Therapeutics|February 11, 2000
CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activityF Sata, A Sapone, G Elizondo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 15, 2001
The use of 3-[2-(N,N-diethyl-N-methylammonium)ethyl]-7-methoxy-4-methylcoumarin (AMMC) as a specific CYP2D6 probe in human liver microsomesN Chauret, B Dobbs, R L Lackman, et al.
Pageof 3